1. OP0103 Identification of optimal subcutaneous doses of tocilizumab in children with systemic juvenile idiopathic arthritis. (12th June 2018) Authors: Brunner, H.; Ruperto, N.; Lovell, D.; Calvo-Penedes, I.; Horneff, G.; Gamir Gamir, M.L.; Hufnagel, M.; Hsu, J.; Bao, M.; Douglass, W.; Mallalieu, N.L.; Wells, C.; Mela, C.M.; De Benedetti, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0237 A comparison of pk and pd outcomes of tocilizumab in giant cell arteritis after sc and iv dosing. (12th June 2018) Authors: Mallalieu, N.L.; Stone, J.H.; Villiger, P.; Klearman, M.; Brockwell, L.; Dimonaco, S.; Charion, J.E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗